Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine, at AACR 2024

TG4050 AACR 2024

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

 

© 2025 Transgene - All rights reserved
Credits